Nieswoiste zapalenia jelit u psów

Piśmiennictwo

1. Achkar J.P., Fiocchi C.: Gene-gene interactions in inflammatory bowel disease: biological and clinical implications. „Am. J. Gastroenterol.”, 2009, 104: 1734-1736.
2. Allenspach K., Luckschander N., Styner M., Seibold F., Doherr M., Aeschbach D., Gaschen F.: Evaluation of assays for perinuclear antineutrophilic cytoplasmic antibodies and antibodies to Saccharomyces cerevisiae in dogs with inflammatory bowel disease. „Am. J. Vet. Res.”, 2004, 65: 1279-1283.
3. Barahona-Garrido J., Sarti H.M., Barahona-Garrido M.K., Hernández-Calleros J., Coss-Adame E., Garcia-Saenz S.M., Yamamoto-Furusho J.K.: Serological markers in inflammatory bowel disease: a review of their clinical utility. „Rev. Gastroenterol. Mex.”, 2009, 74: 230-237.
4. Burgener I.A., König A., Allenspach K., Sauter S.N., Boisclair J., Doherr M.G., Jungi T.W.: Upregulation of toll-like receptors in chronic enteropathies in dogs. „J. Vet. Intern. Med.”, 2008, 22: 553-560.
5. Cave N.J.: Chronic inflammatory disorders of the gastrointestinal tract of companion animals. „N Z Vet. J.”, 2003, 51: 262-274.
6. Cerquetella M., Spaterna A., Laus F., Tesei B., Rossi G., Antonelli E., Villanacci V., Bassotti G.: Inflammatory bowel disease in the dog: differences and similarities with humans. „World J. Gastroenterol.”. 2010, 16: 1050-1056.
7. Chess S., Chess D.: Production of chronic enteritis and other systemic lesions by ingestion of finely divided foreign materials. „Surgery”, 1950, 27: 220-234.
8. Crohn B.B., Ginzburg L., Oppenheimer G.D.: Regional ileitis: a pathologic and clinical entity. 1932. „Mt. Sinai J. Med.”, 2000, 67: 263-268.
9. Davies D.R., O’Hara A.J., Irwin P.J., Guilford W.G.: Successful management of histiocytic ulcerative colitis with enrofloxacin in two Boxer dogs. „Aust. Vet. J.”, 2004, 82: 58-61.
10. German A.J., Hall E.J., Day M.J.: Chronic intestinal inflammation and intestinal disease in dogs. „J. Vet. Intern. Med.”, 2003, 17: 8-20.
11. Greger D.L., Gropp F., Morel C., Sauter S., Blum J.W.: Nuclear receptor and target gene mRNA abundance in duodenum and colon of dogs with chronic enteropathies. „Domest. Anim. Endocrinol.”, 2006, 31: 327-339.
12. Gunawardana S.C., Jergens A.E., Ahrens F.A., Niyo Y.: Colonic nitrite and immunoglobulin G concentrations in dogs with inflammatory bowel disease. „J. Am. Vet. Med. Assoc.”, 1997, 211: 318-321.
13. Hugot J.P., Chamaillard M., Zouali H., Lesage S.: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. „Nature”, 2001, 411: 599-603.
14. Ishihara S., Aziz M.M., Yuki T., Kazumori H., Kinoshita Y.: Inflammatory bowel disease: review from the aspect of genetics. „J. Gastroenterol.”, 2009, 44: 1097-1108.
15. José León A., Garrote J.A., Arranz E.: Cytokines in the pathogenesis of inflammatory bowel diseases. „Med. Clin. (Barc).”, 2006, 127: 145-152.
16. Kleinschmidt S., Meneses F., Nolte I., Hewicker-Trautwein M.: Characterization of mast cell numbers and subtypes in biopsies from the gastrointestinal tract of dogs with lymphocytic-plasmacytic or eosinophilic gastroenterocolitis. „Vet. Immunol. Immunopathol.”, 2007, 120: 80-92.
17. Langhorst J., Elsenbruch S., Koelzer J., Rueffer A., Michalsen A., Dobos G.J.: Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. „Am. J. Gastroenterol.”, 2008, 103: 162-169.
18. Li X., Conklin L., Alex P.: New serological biomarkers of inflammatory bowel disease. „World J. Gastroenterol.”, 2008, 14: 5115-5124.
19. Locher C., Tipold A., Welle M., Busato A., Zurbriggen A., Griot-Wenk M.E.: Quantitative assessment of mast cells and expression of IgE protein and mRNA for IgE and interleukin 4 in the gastrointestinal tract of healthy dogs and dogs with inflammatory bowel disease. „Am. J. Vet. Res.”, 2001, 62: 211-216.
20. Luckschander N., Allenspach K., Hall J., Seibold F., Gröne A., Doherr M.G., Gaschen F.: Perinuclear antineutrophilic cytoplasmic antibody and response to treatment in diarrheic dogs with food responsive disease or inflammatory bowel disease. „J. Vet. Intern. Med.”, 2006, 20: 221-227.
21. Malewska K., Rychlik A., Nieradka R., Kander M.: Treatment of inflammatory bowel disease (IBD) in dogs and cats. „Pol. J. Vet. Sci.”, 2011, 14:165-171.
22. Monsen U., Bernell O., Johansson C.: Prevalence of inflammatory bowel disease among relatives of patients with Crohn’s disease. „Scand. J. Gastroenterol.”, 1991, 26: 302-306.
23. Nikoopour E., Schwartz J.A., Singh B.: Therapeutic benefits of regulating inflammation in autoimmunity. „Inflamm. Allergy Drug Targets.”, 2008, 7: 203-210.
24. Noomen C.G., Hommes D.W., Fidder H.H.: Update on genetics in inflammatory disease. „Best Pract. Res. Clin. Gastroenterol.”, 2009, 23: 233-243.
25. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L.: A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. „Nature”, 2001, 411: 603-606.
26. Perencevich M., Burakoff R.: Use of antibiotics in the treatment of inflammatory bowel disease. „Inflamm. Bowel Dis.”, 2006, 12: 651-664.
27. Rubin D.T., Kornblunth A.: Role of antibiotics in the management of inflammatory bowel disease: a review. „Rev. Gastroenterol. Disord.”, 2005, 5 Suppl. 3: 10-15.
28. Scherding R.G.: Diseases of the large intestine. [In:] Tams T.R., editor: Handbook of Small Animal Gastroenterology. 2^nd ed., Saunders, St. Louis 2003, 251-285.
29. Schreiner N.M., Gaschen F., Gröne A., Sauter S.N., Allenspach K.: Clinical signs, histology, and CD3-positive cells before and after treatment of dogs with chronic enteropathies. „J. Vet. Intern. Med.”, 2008, 22: 1079-1083.
30. Smith M.S., Wakefield A.J.: Crohn’s disease: ancient and modern. „Postgrad. Med. J.”, 1994, 70: 149-153.
31. Stokes J.E., Kruger J.M., Mullaney T., Holan K., Schall W.: Histiocytic ulcerative colitis in three non-boxer dogs. „J. Am. Anim. Hosp. Assoc.”, 2001, 37: 461-465.
32. Sturgess K.: Diagnosis and management of idiopathic inflammatory bowel disease in dogs and cats. „In Practice”, 2005, 27: 291-301.
33. Suchodolski J.S., Steiner J.M.: Laboratory assessment of gastrointestinal function. „Clin. Tech. Small Anim. Pract.”, 2003, 18: 203-210.
34. Suchodolski J.S., Xenoulis P.G., Paddock C.G., Steiner J.M., Jergens A.E.: Molecular analysis of the bacterial microbiota in duodenal biopsies from dogs with idiopathic inflammatory bowel disease. „Vet. Microbiol.”, 2010, 142: 394-400.
35. Sullivan S.N.: Hypothesis revisited: toothpaste and the cause of Crohn’s disease. „Lancet”, 1990, 336: 1096-1097.
36. Tysk C., Lindberg E., Jarnerot G.: Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins: a study of heritability and the influence of smoking. „Gut”, 1988, 29: 990-996.
37. Wdowiak M., Rychlik A., Nieradka R., Kander M., Nowicki M., Szweda M., Depta A.: Diagnosis, tests and difficulties in canine and feline inflammatory bowel disease. „Med. Weter.”, 2014, 70, 460-467.
38. Xenoulis P.G., Palculict B., Allenspach K., Steiner J.M., Van House A.M., Suchodolski J.S.: Molecular-phylogenetic characterization of microbial communities imbalances in the small intestine of dogs with inflammatory bowel disease. „FEMS Microbiol. Ecol.”, 2008, 66: 579-589.
39. Zlotogora J., Zimmerman J., Rachmilewitz D.: Prevalence of inflammatory bowel disease in family members of Jewish Crohn’s disease patients in Israel. „Dig. Dis. Sci.”, 1991, 36: 471-475.
40. Zoran DL.: Fisiopatologia e trattamento delle colopatie nel cane. „Suppl. Veterinaria”, 2001, 15: 19-30.

dr hab. Łukasz Adaszek
Katedra Epizootiologii i Klinika Chorób Zakaźnych
Wydział Medycyny Weterynaryjnej
Uniwersytet Przyrodniczy w Lublinie
20-950 Lublin, ul. Głęboka 30